Patent · US Active

Antibody molecules to C5aR1 and uses thereof

US11773179B2 · kind B2 · utility

0Cited by

44References

4Claims

0Family size

Assignee

Visterra, Inc. · US

Inventors

Karthik Viswanathan · Waltham, US
Brian Booth · Waltham, US
Boopathy Ramakrishnan · Braintree, US
Andrew M. Wollacott · Boston, US
Gregory Babcock · Marlborough, US
Zachary Shriver · Winchester, US

Key dates

Filing date	Jan 13, 2021
Grant date	Oct 3, 2023
Priority date	—
Expiry date	Mar 6, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibody molecules that specifically bind to C5aR1 are disclosed. The antibody molecules can be used to treat, prevent, and/or diagnose disorders, such as ANCA-vasculitis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.